© 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

摘要

The ongoing biomedical nanotechnology has intrigued increasingly intense interests in cerium oxide nanoparticles, ceria nanoparticles or nano-ceria (CeO2-NPs). Their remarkable vacancy-oxygen defect (VO) facilitates the redox process and catalytic activity. The verification has illustrated that CeO2-NPs, a nanozyme based on inorganic nanoparticles, can achieve the anti-inflammatory effect, cancer resistance, and angiogenesis. Also, they can well complement other materials in tissue engineering (TE). Pertinent to the properties of CeO2-NPs and the pragmatic biosynthesis methods, this review will emphasize the recent application of CeO2-NPs to orthopedic biomedicine, in particular, the bone tissue engineering (BTE). The presentation, assessment, and outlook of the orthopedic potential and shortcomings of CeO2-NPs in this review expect to provide reference values for the future research and development of therapeutic agents based on CeO2-NPs.

詳細資料

標題
The Advances of Ceria Nanoparticles for Biomedical Applications in Orthopaedics
作者
Li, Hongru; Xia, Peng; Pan, Su; Qi, Zhiping; Fu, Chuan; Yu, Ziyuan; Kong, Weijian; Chang, Yuxin; Wang, Kai; Wu, Dankai; Yang, Xiaoyu
頁面
7199-7214
區段
Review
出版年份
2020
出版日期
2020
出版者
Taylor & Francis Ltd.
ISSN
1176-9114
e-ISSN
1178-2013
來源類型
學術期刊
出版物語言
English
ProQuest 文件識別碼
2451568457
著作權
© 2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.